MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1101/2024.02.20.24303097

Медицинская библиотека · medRxiv : the preprint server for health sciences · 2024

The aconitate decarboxylase 1/itaconate pathway modulates immune dysregulation and associates with cardiovascular disease markers in SLE.

Patiño-Martinez Eduardo, Nakabo Shuichiro, Jiang Kan, Carmona-Rivera Carmelo, Tsai Wanxia Li, Claybaugh Dillon, Yu Zu-Xi, Romero Aracely, Bohrnsen Eric, Schwarz Benjamin, Solís-Barbosa Miguel A, Blanco Luz P, Naqi Mohammad, Temesgen-Oyelakim Yenealem, Davis Michael, Manna Zerai, Mehta Nehal, Naz Faiza, Brooks Stephen, dell'Orso Stefania, Hasni Sarfaraz, Kaplan Mariana J

ПрепринтСтатьяПеревод в очереди

Аннотация

OBJECTIVE

The Krebs cycle enzyme Aconitate Decarboxylase 1 (ACOD1) mediates itaconate synthesis in myeloid cells.. Previously, we reported that administration of 4-octyl itaconate abrogated lupus phenotype in mice. Here, we explore the role of the endogenous ACOD1/itaconate pathway in the development of murine lupus as well as their relevance in premature cardiovascular damage in SLE.

METHODS

We characterized Acod1 protein expression in bone marrow-derived macrophages and human monocyte-derived macrophages, following a TLR7 agonist (imiquimod, IMQ). Wild type and Acod1-/- mice were exposed to topical IMQ for 5 weeks to induce an SLE phenotype and immune dysregulation was quantified. Itaconate serum levels were quantified in SLE patients and associated to cardiometabolic parameters and disease activity.

RESULTS

ACOD1 was induced in mouse bone marrow-derived macrophages (BMDM) and human monocyte-derived macrophages following in vitro TLR7 stimulation. This induction was partially dependent on type I Interferon receptor signaling and specific intracellular pathways. In the IMQ-induced mouse model of lupus, ACOD1 knockout (Acod1-/-) displayed disruptions of the splenic architecture, increased serum anti-dsDNA and proinflammatory cytokine levels, enhanced kidney immune complex deposition and proteinuria, when compared to the IMQ-treated WT mice. Consistent with these results, Acod1-/- BMDM exposed to IMQ showed higher proinflammatory features in vitro. Itaconate levels were decreased in SLE serum compared to healthy control sera, in association with specific perturbed cardiometabolic parameters and subclinical vascular disease.

CONCLUSION

These findings suggest that the ACOD1/itaconate pathway plays important immunomodulatory and vasculoprotective roles in SLE, supporting the potential therapeutic role of itaconate analogs in autoimmune diseases.

Для цитирования: Patiño-Martinez Eduardo, Nakabo Shuichiro, Jiang Kan, Carmona-Rivera Carmelo, Tsai Wanxia Li, Claybaugh Dillon, Yu Zu-Xi, Romero Aracely, Bohrnsen Eric, Schwarz Benjamin, Solís-Barbosa Miguel A, Blanco Luz P, Naqi Mohammad, Temesgen-Oyelakim Yenealem, Davis Michael, Manna Zerai, Mehta Nehal, Naz Faiza, Brooks Stephen, dell'Orso Stefania, Hasni Sarfaraz, Kaplan Mariana J. The aconitate decarboxylase 1/itaconate pathway modulates immune dysregulation and associates with cardiovascular disease markers in SLE.. medRxiv : the preprint server for health sciences. 2024. DOI: 10.1101/2024.02.20.24303097.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.